St. Johns Investment Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-80
| Closed | -$3.27K | – | 221 |
|
2024
Q3 | $3.27K | Buy |
+80
| New | +$3.27K | ﹤0.01% | 167 |
|
2021
Q4 | – | Sell |
-508
| Closed | -$24K | – | 191 |
|
2021
Q3 | $24K | Hold |
508
| – | – | 0.01% | 108 |
|
2021
Q2 | $25K | Hold |
508
| – | – | 0.01% | 108 |
|
2021
Q1 | $23K | Hold |
508
| – | – | 0.01% | 108 |
|
2020
Q4 | $23K | Hold |
508
| – | – | 0.01% | 103 |
|
2020
Q3 | $24K | Sell |
508
-404
| -44% | -$19.1K | 0.02% | 100 |
|
2020
Q2 | $47K | Hold |
912
| – | – | 0.03% | 98 |
|
2020
Q1 | $43K | Hold |
912
| – | – | 0.04% | 88 |
|
2019
Q4 | $54K | Sell |
912
-570
| -38% | -$33.8K | 0.04% | 90 |
|
2019
Q3 | $79K | Hold |
1,482
| – | – | 0.06% | 83 |
|
2019
Q2 | $74K | Sell |
1,482
-593
| -29% | -$29.6K | 0.06% | 86 |
|
2019
Q1 | $108K | Hold |
2,075
| – | – | 0.08% | 86 |
|
2018
Q4 | $99K | Sell |
2,075
-400
| -16% | -$19.1K | 0.09% | 82 |
|
2018
Q3 | $124K | Sell |
2,475
-176
| -7% | -$8.82K | 0.09% | 82 |
|
2018
Q2 | $134K | Hold |
2,651
| – | – | 0.1% | 85 |
|
2018
Q1 | $129K | Hold |
2,651
| – | – | 0.1% | 82 |
|
2017
Q4 | $118K | Sell |
2,651
-228
| -8% | -$10.1K | 0.09% | 85 |
|
2017
Q3 | $146K | Hold |
2,879
| – | – | 0.11% | 85 |
|
2017
Q2 | $155K | Hold |
2,879
| – | – | 0.12% | 84 |
|
2017
Q1 | $152K | Hold |
2,879
| – | – | 0.12% | 80 |
|
2016
Q4 | $139K | Hold |
2,879
| – | – | 0.11% | 79 |
|
2016
Q3 | $155K | Hold |
2,879
| – | – | 0.13% | 81 |
|
2016
Q2 | $156K | Hold |
2,879
| – | – | 0.14% | 78 |
|
2016
Q1 | $146K | Hold |
2,879
| – | – | 0.13% | 79 |
|
2015
Q4 | $145K | Hold |
2,879
| – | – | 0.13% | 79 |
|
2015
Q3 | $138K | Buy |
+2,879
| New | +$138K | 0.13% | 78 |
|